Skip to main content

Table 1 Baseline characteristics for the whole group

From: Tumor location as an indication for adjuvant radiotherapy in pT3N0 rectal cancer after surgery

Variable

Adjuvant chemotherapy group (n = 150)

Adjuvant chemo-radiotherapy group (n = 115)

P value

Age, year

  

0.041

 median

57

55

 

Gender

  

0.311

 male

95

65

 

 female

55

50

 

Hb g/L

  

0.025

  < 128

67

68

 

  ≥ 128

83

47

 

CEA, ug/mL

  

0.083

  < 5.00

75

70

 

  ≥ 5.00

75

45

 

Tumor Location from AV, cm

  

0.213

  < 7.0

63

58

 

  ≥ 7.0

87

57

 

Tumor grade

  

0.421

 G1

11

5

 

 G2

123

101

 

 G3

16

9

 

Type of surgery

  

0.804

 Mile’s

30

23

 

 Dixon

117

88

 

 Hartmann

3

4

 

Tumor volume, cm3

  

0.083

  < 19

68

65

 

  ≥ 19

82

50

 

Retrieved lymph nodes

  

0.174

  < 14

69

63

 

  ≥ 14

81

52

 

Lymph vascular invasion

  

0.808

 yes

11

7

 

 no

139

108

 

Duration of adjuvant therapy, months

   

 median

5.3 (4.5–6.2)

5.0 (4.4–6.1)

0.485

Follow-up, months

  

0.872

 median

57.1

56.4

 
  1. Abbreviations: adjuvant-chemo adjuvant chemotherapy, Hb hemoglobin, CEA carcinoembryonic antigen, AV anal verge, tumor grade: G1 well differentiated, G2 moderately differentiated, G3 poorly differentiated